X-linked signal elements (XSEs) communicate the dose of X chromosomes to the regulatory-switch gene Sex-lethal (Sxl) during Drosophila sex determination. Unequal XSE expression in precellular XX and XY nuclei ensures that only XX embryos will activate the establishment promoter, SxlPe, to produce a pulse of the RNA-binding protein, SXL [1] . Once XSE protein concentrations have been assessed, SxlPe is inactivated and the maintenance promoter, SxlPm, is turned on in both sexes; however, only in females is SXL present to direct the SxlPm-derived transcripts to be spliced into functional mRNA [2, 3] . Thereafter, Sxl is maintained in the on state by positive autoregulatory RNA splicing [2] . Once set in the stable on (female) or off (male) state, Sxl controls somatic sexual development through control of downstream effectors of sexual differentiation and dosage compensation [1, 4] . Most XSEs encode transcription factors that bind SxlPe, but the XSE unpaired (upd) encodes a secreted ligand for the JAK/STAT pathway [5] [6] [7] . We show that although STAT directly regulates SxlPe, it is dispensable for promoter activation. Instead, JAK/STAT is needed to maintain high-level SxlPe expression in order to ensure Sxl autoregulation in XX embryos. Thus, upd is a unique XSE that augments, rather than defines, the initial sex-determination signal.
Summary
X-linked signal elements (XSEs) communicate the dose of X chromosomes to the regulatory-switch gene Sex-lethal (Sxl) during Drosophila sex determination. Unequal XSE expression in precellular XX and XY nuclei ensures that only XX embryos will activate the establishment promoter, SxlPe, to produce a pulse of the RNA-binding protein, SXL [1] . Once XSE protein concentrations have been assessed, SxlPe is inactivated and the maintenance promoter, SxlPm, is turned on in both sexes; however, only in females is SXL present to direct the SxlPm-derived transcripts to be spliced into functional mRNA [2, 3] . Thereafter, Sxl is maintained in the on state by positive autoregulatory RNA splicing [2] . Once set in the stable on (female) or off (male) state, Sxl controls somatic sexual development through control of downstream effectors of sexual differentiation and dosage compensation [1, 4] . Most XSEs encode transcription factors that bind SxlPe, but the XSE unpaired (upd) encodes a secreted ligand for the JAK/STAT pathway [5] [6] [7] . We show that although STAT directly regulates SxlPe, it is dispensable for promoter activation. Instead, JAK/STAT is needed to maintain high-level SxlPe expression in order to ensure Sxl autoregulation in XX embryos. Thus, upd is a unique XSE that augments, rather than defines, the initial sex-determination signal.
Results and Discussion
The question of how embryos differentiate between precise 2-fold differences in X-linked signal element (XSE) doses is central to understanding how genetic constitution defines sexual fate. Current X-chromosome-counting models posit that the female fate is set when XSE proteins exceed a threshold concentration and activate SxlPe [1, 8, 9] . The XSE threshold is set by interactions between the XSEs and other proteins in the embryo. Some XSEs interact with maternally supplied proteins to form dose-sensitive transcription factors, such as Scute/Daughterless, that bind SxlPe [10] , but XSE doses are also assessed with reference to maternally and zygotically expressed repressors [11, 12] . Three XSE proteins, SisA, Scute, and Runt, are viewed as acting similarly by binding directly to and activating SxlPe. The fourth XSE, unpaired (upd, also called outstretched or sisC), encodes a secreted ligand that signals through the JAK kinase (hopscotch) to activate the Stat92E transcription factor [7, 13] . Although upd meets the criteria of an XSE [6, 14] , its effects on sex determination are weaker than those of sisA, scute, and runt, and changes in its gene dose have only moderate effects on Sxl [5, 6, 15, 16] . To understand how this comparatively dose-insensitive XSE regulates sex, we first examined when and where upd, JAK, and STAT act on the Sxl switch.
upd is Expressed Later Than Other XSEs Using in situ hybridization, we defined the early embryonic expression pattern of upd. We found no evidence for maternally supplied transcripts and observed that upd mRNA was first detectable in nuclear cycle 13 ( Figure 1 ). The fact that the first upd transcripts were present throughout the embryo, including at the poles, is consistent with the distribution of phosphorylated Stat92E [17] . As cellularization progressed past early cycle 14, the upd pattern resolved into indistinct stripes that developed into a 14 stripe pattern during gastrulation [7] . Our results show that upd expression begins later than that of the other XSEs (sisA in cycle 8; scute in cycle 9) and also, paradoxically, that it begins after the onset of transcription of its target, Sxl, in cycle 12 [18] [19] [20] .
upd Is Needed to Express SxlPe in the Central Regions of the Embryo To understand how upd functions in Sxl activation and how it differs from other XSEs, we examined upd mutations for their effects on SxlPe by using in situ hybridization and on Sxl protein levels by using immunostaining with SXL antibody. Significantly, our RNA probes detected nascent Sxl transcripts, allowing us to monitor both the spatial and temporal responses of SxlPe on a cell-cycle by cell-cycle basis [18, 19, 21] .
We first examined upd sisC1
, a loss-of-function mutation that appears to specifically affect sex determination, because it has no observable effect on later upd functions [6] . Consistent with the fact that upd has a modest effect on SxlPe, we found that two-thirds of homozygous upd sisC embryos (n = 225) expressed SxlPe in a manner indistinguishable from that of the wild-type. A small proportion of embryos, 15%, had within their middle sections several clusters of 5-15 nuclei that did not express SxlPe (Figure 2 ), whereas the remaining 18% had severe defects, with SxlPe expression being absent from most of the central regions of the embryos. Despite early aberrations in SxlPe activity, immunostaining revealed no lasting defect in the expression of SXL, because upd sisC1 embryos that reached germband extension stained in a 1:1 male:female ratio (Figure 2) . To determine the effects of a complete loss of zygotic upd activity, we examined upd
YC43
, a probable null mutation, and the deficiency Df(1)ue69, which deletes upd and the upd-like gene, upd3 [6, 22] . With respect to SxlPe, we found that upd-null-mutant females were *Correspondence: jerickson@mail.bio.tamu.edu more severely affected than were upd sisC1 embryos. At cellularization, the defects ranged from embryos containing large clusters of nuclei that did not express SxlPe in the central part of embryo to those in which the entire central region failed to express the promoter (Figure 2 ; data not shown). The poles, however, expressed SxlPe normally. Immunostainings of upd YC43 and Df(1)ue69 embryo collections revealed that these alleles had strong but incompletely penetrant effects on the later distribution of SXL. The fact that an estimated 40% of mutant female embryos stage 6 and older failed to express SXL in their central regions is consistent with the observed defects in SxlPe activity ( Figure 2 ). The remainder eventually expressed normal levels of SXL in all their tissues, indicating that most upd mutant females were able to compensate for reduced SxlPe activity and ultimately engaged autoregulatory Sxl mRNA splicing. Two upd-like genes, upd2 and upd3, map adjacent to upd [23] . Loss of zygotic upd2 [22] had no effect on SxlPe, and the effects of Df (1) To eliminate JAK/STAT activity completely, we used the dominant female-sterile technique [24] to generate females lacking maternal hopscotch (hop) or Stat92E, which encode the only JAK kinase and STAT in Drosophila [25, 26] . We expected that by removing maternal hop, STAT would remain unphosphoryated, allowing us to determine the effects of the loss of the entire pathway on SxlPe.
When we examined Sxl expression in cycle 14 embryos derived from hop C111 germline clones, we found that SxlPe was active in the anterior and posterior regions of the embryos but almost completely inactive in the central region of the embryos ( Figure 2 ). In contrast to the results with upd mutants and deficiencies, all of which exhibited considerable embryo-to-embryo variation, loss of maternal hop had nearly identical effects on SxlPe in every embryo. This more potent effect of maternal hop C111 as compared to upd mutants suggests that zygotic Upd might not be the only activator of JAK in the precellular embryo.
We confirmed our findings with hop C111 by using the Stat92E 06346 mutation. Cycle 14 embryos derived from Stat92E 06346 germline clones also lacked nearly all SxlPe expression in their central regions, but they were even more strongly affected than hop C111 females because SxlPe activity was also reduced in the termini (Figure 2 ). These findings are contrary to predictions of a linear JAK/STAT pathway going from zygotic Upd through receptor and kinase to activated STAT. Instead, the progressive weakening of SxlPe by removal of upd and Stat92E suggests that there is hop-independent control of Stat92E function in sex determination. The possibility of cross-talk between signaling systems is supported by the finding that the torso receptor-tyrosine-kinase pathway activates STAT92E in the embryo termini [27, 28] .
JAK/STAT Is Needed to Maintain SxlPe Activity Only after Cycle 13
Although the hop C111 and Stat92E 06346 mutations had large effects on SxlPe during cycle 14, the period of maximum SxlPe expression, we found that these mutations had little effect on SxlPe at earlier stages. In wildtype females, SxlPe is first activated in cycle 12 [18, 19] . Expression increases throughout cycle 13 and reaches a peak in the first minutes of cycle 14 ( Figure 3 ). In embryos from hop C111 mothers, SxlPe was expressed as in the wild-type during cycles 12 and 13. However, upon entry into cycle 14, SxlPe activity ceased in the middle sections of the embryos (Figure 3) . A similar phenomenon was observed in embryos carrying strong upd mutants and in those derived from Stat92E 06346 germline clones (data not shown). These results show that JAK/ STAT, and thus upd XSE function, is not needed for the initial activation of SxlPe. Instead, upd must function as a different kind of XSE: one dispensable for the initial assessment of X-chromosome dose, but needed to In situ hybridization to upd mRNA in cycle 1-12 embryos (cycle 10 is shown) revealed no maternal contribution of upd. Zygotic upd transcripts were first detected during nuclear cycle 13. During mid to late cellularization (cycle 14), upd mRNA resolves into faint stripes. By germband extension (gbe), upd stripes are fully formed.
maintain SxlPe activity in the final stage of the X-counting process.
Autoregulation Can Rescue Earlier Defects in SxlPe Activity
When we examined the progeny of hop C111 mutant mothers for Sxl protein, we found that defects in SxlPe expression led to a permanent failure to express SXL in the central regions in 35% of female embryos (n = 188) (Figure 2 ). This suggests that the loss of SxlPe activity in cycle 14 can reduce the level of early SXL to below the threshold normally required to activate autoregulatory mRNA splicing. Although 35% of female embryos were defective for later SXL expression, most females that completed gastrulation expressed SXL uniformly. This striking discordance between the effects of hop (and upd and Stat92E) mutants on SxlPe activity and ultimate SXL levels suggests that stable Sxl autoregulation can be established even when SxlPe function has been seriously compromised. Although some rescuing Sxl mRNA or protein may have diffused from the poles, an alternative explanation is that expression of SxlPe during cycles 12 and 13 might often have provided sufficient SXL to trigger autoregulation once the maintenance promoter, SxlPm, had been activated.
STAT-Binding Sites at SxlPe
SxlPe is thought to have two main functional elements: a proximal 390 bp X-counting region responsible for sex-specific activation, and a more distal (to 21.4 kb) element that elevates Sxl transcription [8, 10, 29] . Three predicted STAT-binding sites are located in these elements at positions 2253, 2393, and 2428 bp (Figure 4 ). To test their roles, we changed consensus TTC sequences to TTT because such changes block binding by STAT92E [26] and the mammalian homologs STATs 5 and 5a [30] . In situ hybridizations revealed that the mutation in the proximal STAT site, S1, greatly reduced the number of nuclei expressing SxlPe-lacZ, creating a patchy staining pattern and lower overall mRNA levels ( Figure 4 ). Mutations in S1 and S2, or in all three sites together, caused a strong but variable loss of SxlPe-lacZ expression in most nuclei, resulting in dramatically reduced accumulation of lacZ mRNA. Although the S1, S2, S3 mutant appeared to have a slightly stronger effect than the double mutant, both transgenes exhibited phenotypes reminiscent of those seen in embryos derived from Stat92E 06346 germline clones (Figures 2 and 4) . Our results show that STAT92E acts through the consensus binding sites at SxlPe.
Conclusions
SxlPe is remarkable for both its rapid response and exquisite sensitivity to X-chromosome dose. In male embryos, it is always off. In female embryos, SxlPe is strongly expressed, but only during a 35-40 min period from mid cycle 12 until about 10-15 min into cycle 14 [12, 19] . Given these time constraints, many have assumed that all XSEs would function to establish the initial on or off state of SxlPe. However, we found that upd behaved very differently than sisA and scute, both of which are required for SxlPe activation and expression [15] . Loss of upd or the JAK/STAT pathway had little or no effect on SxlPe during cycles 12 or 13. Instead, JAK/ STAT mutations blocked SxlPe expression late in the process, during cycle 14 ( Figure 4) . We interpret this observation as revealing that SxlPe is regulated in two mechanistically distinct phases: the first controlling the initial response to X-chromosome dose, and the second acting to maintain or reinforce the initial decision.
The relatively late actions of upd and hop offer explanations for several puzzling aspects of upd's function in sex determination. First, upd is considered a weak XSE. This is both because Sxl is comparatively insensitive to upd dose and because loss of upd or JAK/STAT function doesn't eliminate Sxl expression [5, 6, 16] . Both effects are consistent with expectations of a two-step, initiation and maintenance, model for SxlPe function. JAK/STAT mutations would not be expected to eliminate all Sxl function in a two-step model because the STAT-independent initiation step would produce Sxl mRNA and protein. The exact gene dose of upd would not be particularly important for sex because excess active STAT could not induce SxlPe without the prior actions of the initiating XSEs and because even a single dose of upd + could provide enough active STAT to augment an earlier decision to become female. Thus, the proposed STAT maintenance function explains both the failure of the constitutively active hop tum-l allele to induce ectopic SxlPe expression in males and the ability of hop tum-l to further stimulate SxlPe activity in females [5] . Likewise, the requirement for STAT site S2, located just distal to the 390 bp X-counting region of SxlPe (Figure 4) , and the finding that upd is first expressed after Sxl (Figure 1 ) can be explained if STAT's role is to bolster transcription from SxlPe in embryos that already have counted two Xs. Although neither essential for SxlPe expression nor highly dose sensitive, upd, hop, and Stat92E nonetheless play important roles at SxlPe. In their absence, the period of SxlPe activity is cut short, reducing the concentration of SXL and preventing a large fraction of embryos from engaging the maintenance mode of Sxl expression.
How might STAT92E function in a two-step model? One possibility is that STAT might antagonize the lateacting repressor Dpn [12, 18] . Alternatively, the STAT transcription factor might augment, stabilize, or replace earlier-acting XSE activator complexes as their concentrations diminish in cycle 14. BAP60, a core component of the Brahma chromatin-remodeling complex, has been shown to interact with two components of the sex-determination signal [31] . If STAT92E also interacts with the Brahma complex [32] , it might maintain SxlPe chromatin in an active state, facilitating the restoration of transcription after the 13 th mitosis. Understanding the commonalities and unique mechanisms STATs employ in their multitude of roles is a fundamental goal of research on this ubiquitous signaling pathway [13] . It is also essential for understanding why the pathway has so often been co-opted into new roles during evolution. As discussed by Zeidler et al. [33] , STATS seem primarily permissive rather than instructive. They are rarely the primary signals defining cell fate. In these respects, comparison of the even-skipped (eve) stripe 3 enhancer and SxlPe reveals interesting parallels [26, 33] . Both SxlPe and eve stripe 3 are regulated by the balance between several activators and repressors. The responses of both elements to JAK/STAT signaling are extremely rapid, occurring within the dynamic environment of the precellular embryo. Stat92E is important for each, but its roles augment the actions of other factors, rather than being responsible for defining the initiating signals. Mutation of S1 reduced overall lacZ expression and decreased the number of expressing nuclei. The S1, S2 and S1, S2, S3 mutations greatly reduced overall lacZ mRNA levels and the number of expressing nuclei, causing patchy staining.
With respect to the evolution of the sex signal, it has been proposed that a diffusible JAK/STAT signal might have been recruited to allow non linear signal amplification or, alternatively, that a diffusible ligand might render SxlPe less sensitive to random fluctuations in cell-autonomous XSE protein concentrations [5, 34] . Although the weak dose dependence of upd argues against signal amplification, a buffering function is consistent with existing data. Our findings suggest another possibility. STAT proteins respond rapidly to a range of regulatory signals [13] ; it may be this ability to act within a matter of minutes that brought JAK/STAT into the temporally dynamic X-chromosome-counting process. 
In Situ Hybridization and Immunohistochemistry
In situ hybridization used digoxygenin-labeled antisense RNA and NBT/BCIP staining [18, 35] . DAPI-stained embryos were mounted in 70% glycerol. Staging was based on nuclear number, shape, and density [36] . Templates for probe synthesis had a T7 promoter added during PCR. The template sequences used were Sxl, 383 bp, spanning 5 0 -TCGCTTGT.CACACACA-3 0 from the intron after exon E1; upd, 421 bp, spanning 5 0 -GCACACTG.TCGACTTC-3 0 ; and lacZ, 350 bp, 5 0 -ATAGCGAT.AAATTGCC-3 0 . See the Supplemental Data for complete primer sequences.
Immunodetection used mouse SXL polyclonal antibody at 1:500 dilution [37] and HRP-conjugated rabbit anti-mouse antibodies [38] . After DAB staining, embryos were mounted in Canada balsam. Phenotypes were quantified by counting all stained embryos on representative slides. Repeated experiments produced indistinguishable results.
Cloning and Mutagenesis
Point mutations were made with QuickChange in vitro mutagenesis (Stratagene). SxlPe (1.4 kb) in pT-Easy (Promega) was the template, and mutagenic primers covered STAT sites 1 (5 0 -GCTTtCGAGAA TG-3 0 ), 2 (5 0 -TGTTtACAGAATG-3 0 ), and 3 (5 0 -CGTTtTAAGAATC-3 0 ). See the Supplemental Data for complete primer sequences. Mutant SxlPe segments were cloned into EcoR1 and Not 1 sites of a modified pCaSpeR-AUG-b-Gal vector [10] . For the wild-type and STAT site 1, transformants were obtained by coinjection with the pTurbo transposase source. For STAT sites 1,2 and 1,2,3, transformation was by Genetic Services. Two independent lines were each examined by in situ hybridization with lacZ probes. Little or no line-toline variation was observed.
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Supplemental Data include primer sequences and are available with this article online at: http://www.current-biology.com/cgi/content/ full/17/7/643/DC1/.
